Multiple sclerosis and related disorders · 2025
Neuromyelitis optica spectrum disorders and their overlap with myasthenia gravis in a single center in Argentina.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Villa Andrés M, Analisa Manin, Guerrero Diego Alarcon, Seimandi Carla, Simison Conrado, Saffe Valentina, Aguirre Florencia
Аннотация
BACKGROUND: The incidence of neuromyelitis optica spectrum disorder (NMOSD) in association with other autoimmune diseases is frequent. The coexistence of myasthenia gravis (MG) and NMOSD has been reported, showing a higher-than-expected likelihood of co-occurrence. The aim of this study is to describe the overlap between NMOSD and MG and to analyze these cases within two large real-world cohorts of patients with AQP4 antibody-positive NMOSD and AChR antibody-positive MG in Argentina.
METHODS: A cross-sectional, retrospective study was conducted at a referral center in Buenos Aires, Argentina, including patients with AQP4-Ab-positive NMOSD and AChR-Ab-positive MG.
RESULTS: A total of 389 medical records were reviewed: 108 NMOSD and 281 MG cases. Among them, 77 patients were AQP4-IgG positive, and 207 were AChR-Ab positive. Three out of 77 AQP4-IgG-positive patients had MG with AChR-Ab positivity, accounting for 3.89% of NMOSD cases. Conversely, three out of 207 AChR-Ab-positive MG patients (1.45 %) had AQP4-IgG-positive antibodies. Patients with concurrent MG and NMOSD were female, had a late onset of NMOSD, and experienced MG onset before NMOSD. They also showed a good response to NMOSD treatment with immunosuppressive therapy. Two patients had undergone thymectomy before NMOSD onset. No patient was receiving immunosuppressive treatment at the time of NMOSD onset.
CONCLUSIONS: A total of 3.89 % of AQP4-Ab-positive NMOSD patients had overlapping AChR-Ab-positive MG. This is the first report assessing the association between NMOSD and MG in Argentinian and Latin American (LATAM) patients.
METHODS: A cross-sectional, retrospective study was conducted at a referral center in Buenos Aires, Argentina, including patients with AQP4-Ab-positive NMOSD and AChR-Ab-positive MG.
RESULTS: A total of 389 medical records were reviewed: 108 NMOSD and 281 MG cases. Among them, 77 patients were AQP4-IgG positive, and 207 were AChR-Ab positive. Three out of 77 AQP4-IgG-positive patients had MG with AChR-Ab positivity, accounting for 3.89% of NMOSD cases. Conversely, three out of 207 AChR-Ab-positive MG patients (1.45 %) had AQP4-IgG-positive antibodies. Patients with concurrent MG and NMOSD were female, had a late onset of NMOSD, and experienced MG onset before NMOSD. They also showed a good response to NMOSD treatment with immunosuppressive therapy. Two patients had undergone thymectomy before NMOSD onset. No patient was receiving immunosuppressive treatment at the time of NMOSD onset.
CONCLUSIONS: A total of 3.89 % of AQP4-Ab-positive NMOSD patients had overlapping AChR-Ab-positive MG. This is the first report assessing the association between NMOSD and MG in Argentinian and Latin American (LATAM) patients.